Angitia Biopharmaceuticals
Clinical trials sponsored by Angitia Biopharmaceuticals, explained in plain language.
-
New Bone-Boosting drug shows promise for women with osteoporosis
Disease control OngoingThis study tests a new medicine called AGA2118 in postmenopausal women aged 55 to 80 who have low bone density but no prior fractures. The goal is to see if it can safely increase bone strength in the spine and hips compared to a placebo over 12 months. Participants will receive …
Phase: PHASE2 • Sponsor: Angitia Biopharmaceuticals • Aim: Disease control
Last updated May 26, 2026 10:14 UTC
-
New injection aims to boost spinal fusion success in back pain patients
Disease control OngoingThis study tests a single injection of AGA111 given directly into the spine during lumbar fusion surgery for people with degenerative disc disease. The goal is to see if it improves bone healing and reduces pain and disability compared to a placebo. About 412 adults aged 18 to 80…
Phase: PHASE3 • Sponsor: Angitia Biopharmaceuticals • Aim: Disease control
Last updated May 26, 2026 08:20 UTC